ATHENEX INC
Summary
Athenex operates as a biopharmaceutical company. The Company offers discovery, development, and commercialization of novel therapies for the treatment of cancer. Athenex serves patients globally.
Deals Overview
Total Deals2
Valued Deals1
Total Value£ 133 M
Avg. Deal Size£ 133 M
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
